Abstract
The IL-17 pathways are involved in the pathophysiology of many inflammatory skin conditions, including hidradenitis suppurativa. Secukinumab, an IL-17A inhibitor, has been used for years in inflamm... Plain language summary Hidradenitis suppurativa is a chronic skin disorder characterized by recurrent painful bumps, tunnels underneath the skin and significant scarring. To date, the only US FDA-a... Tweetable abstract Secukinumab, an IL-17A inhibitor, has been used for years in inflammatory skin disorders such as psoriasis. We review its role in the treatment of hidradenitis suppurativa (HS).
Funding Information
  • National Psoriasis Foundation.

This publication has 38 references indexed in Scilit: